2b16: Difference between revisions

New page: left|200px<br /> <applet load="2b16" size="450" color="white" frame="true" align="right" spinBox="true" caption="2b16, resolution 1.75Å" /> '''The crystal structu...
 
No edit summary
Line 1: Line 1:
[[Image:2b16.gif|left|200px]]<br />
[[Image:2b16.gif|left|200px]]<br /><applet load="2b16" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2b16" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2b16, resolution 1.75&Aring;" />
caption="2b16, resolution 1.75&Aring;" />
'''The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Tyr78Phe'''<br />
'''The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Tyr78Phe'''<br />


==Overview==
==Overview==
Systemic deposition of transthyretin (TTR) amyloid fibrils is always, observed in familial amyloidotic polyneuropathy, senile systemic, amyloidosis and familial amyloidotic cardiomyopathy patients., Destabilization of the molecule leads to a cascade of events which result, in fibril formation. The destabilization of a native protein with, consequent conformational changes appears to be a common link in several, human amyloid diseases. Intensive research has been directed towards, finding small molecules that could work as therapeutic agents for the, prevention/inhibition of amyloid diseases through stabilization of the, native fold of the potentially amyloidogenic protein. This work provides, insight into the structural determinants of the highly stabilizing effects, of 2,4-dinitrophenol on wild-type TTR. It is also shown that similar, interactions are established between this molecule and two highly, amyloidogenic TTR variants: TTR L55P and TTR Y78F. In the three crystal, complexes, 2,4-dinitrophenol occupies the two hormone-binding sites of the, TTR tetramer. As a result of 2,4-dinitrophenol binding, the two dimers in, the TTR tetramer become closer, increasing the stability of the protein., The three-dimensional structures now determined allow a comprehensive, description of key interactions between transthyretin and, 2,4-dinitrophenol, a small compound that holds promise as a template for, the design of a therapeutical drug for amyloid diseases.
Systemic deposition of transthyretin (TTR) amyloid fibrils is always observed in familial amyloidotic polyneuropathy, senile systemic amyloidosis and familial amyloidotic cardiomyopathy patients. Destabilization of the molecule leads to a cascade of events which result in fibril formation. The destabilization of a native protein with consequent conformational changes appears to be a common link in several human amyloid diseases. Intensive research has been directed towards finding small molecules that could work as therapeutic agents for the prevention/inhibition of amyloid diseases through stabilization of the native fold of the potentially amyloidogenic protein. This work provides insight into the structural determinants of the highly stabilizing effects of 2,4-dinitrophenol on wild-type TTR. It is also shown that similar interactions are established between this molecule and two highly amyloidogenic TTR variants: TTR L55P and TTR Y78F. In the three crystal complexes, 2,4-dinitrophenol occupies the two hormone-binding sites of the TTR tetramer. As a result of 2,4-dinitrophenol binding, the two dimers in the TTR tetramer become closer, increasing the stability of the protein. The three-dimensional structures now determined allow a comprehensive description of key interactions between transthyretin and 2,4-dinitrophenol, a small compound that holds promise as a template for the design of a therapeutical drug for amyloid diseases.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2B16 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with DNF as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2B16 OCA].  
2B16 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=DNF:'>DNF</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2B16 OCA].  


==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Damas, A.M.]]
[[Category: Damas, A M.]]
[[Category: Morais-de-Sa, E.]]
[[Category: Morais-de-Sa, E.]]
[[Category: Neto-Silva, R.M.]]
[[Category: Neto-Silva, R M.]]
[[Category: Pereira, P.J.]]
[[Category: Pereira, P J.]]
[[Category: Saraiva, M.J.]]
[[Category: Saraiva, M J.]]
[[Category: DNF]]
[[Category: DNF]]
[[Category: 2]]
[[Category: 2]]
Line 29: Line 28:
[[Category: transthyretin]]
[[Category: transthyretin]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:57:05 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:33:06 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA